The Institute for Clinical and Economic Review (ICER) is an independent non-profit organization that evaluates the evidence on the value of medical tests, treatments, and delivery systems innovations to improve patient care and control medical costs.
For managed care professionals, ICER reports have become an increasingly important part of formulary decision-making and the framing of coverage criteria. These reports are evidence-based and provide valuable information including comparative clinical effectiveness, insights from patients and clinical experts, incremental cost-effectiveness, and potential budget impact.
What are the latest developments in the methods ICER uses to develop its reports? How are these methods tailored to handle cell and gene therapies or other treatments that are single or short-term therapies and hold potential to be curative? In addition to methods based on the quality-adjusted life year (QALY), what are the other ways ICER reports evaluate health improvements from treatment? And what are the innovative ways that payers, life science companies, and others are applying these reports in benefit design, price negotiation, and formulary development? What is on the horizon in the coming year?
This session will address these questions and provide a window into the rapidly evolving use of ICER reports within managed care pharmacy.
At the completion of this program, participants should be able to:
- Summarize the process and type of data utilized to develop Institute for Clinical and Economic Review (ICER) reports.
- Identify the ways that ICER reports incorporate the patient perspective and how this may impact health disparities.
- Explain at least 3 ways that managed care professionals and other key stakeholders can use ICER reports in their practice.
- Discuss how ICER reports may evolve in the future and how this will impact managed care professionals.
Steven D. Pearson, MD, MSc
Institute for Clinical and Economic Review
Schedule of Educational Activity:
This activity consists of an audio recording, pre-test assessment questions (not required to pass or continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation.
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN: 0233-0000-21-029-H04-P • Activity Type: Knowledge-Based
Contact Hours: 1
Release Date: July 6, 2021 • Expiration Date: December 31, 2022
Activity Fee: Free for Members and $50 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP 2021 Virtual.CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
System Technical Requirements/Viewing Requirements:
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE UAN #0233-0000-21-029-H04-P||1 Contact Hour||June 16, 2021 - December 31, 2022|